#Covaxin #Covishield #COVID19 #SARS-CoV-2 #BharatBiotech

In one of my last videos on COVID-19 vaccines, I talked about the denial of Covaxin import by ANVISA, Brazil's regulatory agency on the basis of Bharat Biotech having issues related to Good Manufacturing Practices (GMP). Now on 4th of June 2021, Covaxin was granted approval by ANVISA, with strict conditions regarding quality control. In this video, I talk about the new data out regarding safety and efficacy of coronavirus vaccines available in India, as well as some pending issues regarding clinical trial data availability.

свернуть